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PeptidomicsPolycationic peptidesmay present their C-termini in either amidated or acidic form; however, the effects of these
conformations on the mechanisms of interaction with the membranes in general were not properly investigated
up to now. Protonectarina-MP mastoparan with an either amidated or acidic C-terminus was utilized to study
their interactions with anionic and zwitterionic vesicles, using measurements of dye leakage and a combination
of H/D exchange and mass spectrometry to monitor peptide–membrane interactions. Mast cell degranulation,
hemolysis and antibiosis assays were also performed using these peptides, and the results were correlated
with the structural properties of the peptides. The C-terminal amidation promotes the stabilization of the second-
ary structure of the peptide, with a relatively high content of helical conformations, permitting a deeper interac-
tionwith the phospholipid constituents of animal and bacterial cellmembranes. The results suggested that at low
concentrations Protonectarina-MP interacts with themembranes in away that both terminal regions remain po-
sitioned outside the external surface of the membrane, while the α-carbon backbone becomes partially embed-
ded in the membrane core and changing constantly the conformation, and causing membrane destabilization.
The amidation of the C-terminal residue appears to be responsible for the stabilization of the peptide conforma-
tion in a secondary structure that is richer in α-helix content than its acidic congener. The helical, amphipathic
conformation, in turn, allows a deeper peptide–membrane interaction, favoring both biological activities that de-
pend onpeptide structure recognition by theGPCRs (such as exocytosis) and those activities dependent onmem-
brane perturbation (such as hemolysis and antibiosis).
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) have inspired the development of
novel antimicrobial agents against resistant microorganisms. Many in-
vestigations have focused on the design of novel peptides that present
increased antimicrobial activity, compared to the natural ones used as
models, without damaging the cells of the host organisms, which are
generally mammals [1]. The improvements in the level of antimicrobial
activity have been developed in parallel with efforts to eliminate side-
effects, such as the cytotoxicity against mammalian cells. Most of the
variables considered during the engineering processes of the novel pep-
tides generally correspond to the physicochemical parameters of these
peptides, such as chain length, amphipathicity, α-helical content, net
positive charge and hydrophobicity [2,3].niversidade Estadual Paulista
razil. Tel.: +55 19 35264163;Mastoparans are amidated tetradecapeptides, characteristic of the
venoms from social wasps, that cause mast cell degranulation and/or
cell disruption; these peptides are present from two to four lysine
residues in their sequences [4]. The hydrophobic nature of most of
the amino acid residues in mastoparans usually leads them to
adopt amphipathic α-helical conformations in micellar solvents [5]
and in a membrane-bound state [6]. The cationicity of mastoparans
contributes to the formation of discriminate anionic vesicles, which
favor their antimicrobial activity [7–9]. The relative positioning of
both cationic and hydrophobic residues within the peptides favors
their interactions with the zwitterionic membranes of mammalian
cells, and, therefore, some of these peptides can cause mast cell de-
granulation and hemolysis [8].
Differentmechanisms to explain the actions of antibacterial peptides
are currently understood: (i) in the barrel-stave model, monomers of
the peptides associate with each other to form a bundle of helices that
are embedded in the membrane, forming a transmembrane channel
[10,11]; and, (ii) in the carpet model, the peptides act like deter-
gents, forming eventually toroidal pores [12,13]. In both models,
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charge distribution, net charge, molecular volume, amphipathicity
and oligomeric state in solution, play essential roles in the interac-
tions between the peptide and the membrane surface and/or with
the membrane core.
The number and distribution of amino acid residues along the se-
quence inﬂuence the amphipathicity and net positive charge of the pep-
tides, which in turn affect the interaction between themastoparans and
the membranes. It was previously reported that the deamidation of the
C-terminus of the membrane-active peptide EMP-AF1 reduces its anti-
microbial potency [5], while suppressing its hemolytic activity [14].
The enhanced potency of inﬂammatory peptides with amidated C-
terminal residues is attributed to the increased positive charge at the
N-terminus, which appears to promote the interaction between these
peptides and the predominantly negatively-charged bacterial mem-
branes [15–18]. This aspect facilitates the interaction between the pep-
tides and the cell membrane, leading to membrane permeabilization
[19].
Solution-phase hydrogen/deuterium (H/D) exchange, in combi-
nation with electrospray ionization mass spectrometry (ESI-MS),
has become a useful tool for studying protein structure, protein–
protein interactions, and the assignment of protein–membrane
interfacial regions [20]. To investigate the role of the C-terminus of
mastoparan peptides, either as an amide or as a free acid, in deter-
mining the molecular structures and biological activities of these
peptides, the mastoparan peptide Protonectarina-MP [21] was used as
molecularmodel. The secondary structures of both forms of this peptide
were investigated using CD spectroscopy andmolecularmodeling. Pep-
tides with an either amidated or acidic C-terminus were utilized to
study their interactions with anionic and zwitterionic vesicles, using
measurements of dye leakage and a combination of H/D exchange and
mass spectrometry to monitor peptide–membrane interactions. Mast
cell degranulation, hemolysis and antibiosis assayswere also performed
using these peptides, and the resultswere correlatedwith the structural
properties of the peptides.2. Material and methods
2.1. Peptide synthesis and HPLC puriﬁcation
The peptides, Protonectarina-MP-NH2 (INWKALLDAAKKVL-NH2)
and its analogue Protonectarina-MP-OH (INWKALLDAAKKVL-OH),
were prepared by step-wise manual solid phase synthesis, using
N-9-ﬂuorophenylmethoxy-carbonyl (Fmoc) chemistry and Novasyn
TGS resin (Novabiochem). The side-chain protective groups includ-
ed β-t-butyl ester for aspartic acid, N-β-trityl for asparagine and t-
butoxycarbonyl for lysine. Cleavage of the peptide–resin complexes
was performed by treatment with triﬂuoroacetic acid (TFA)/1, 2-
ethanedithiol/anisole/phenol/water (82.5:2.5:5:5:5 by volume),
using 10 mL per gram of the complex at room temperature for 2 h.
After ﬁltering to remove the resin, anhydrous diethyl ether
(Sigma) at 4 °C was added to the soluble material to precipitate
the crude peptide, which was collected as a pellet by centrifugation
at 1000 ×g for 15min at room temperature. The crude peptides were
dissolved in water and chromatographed under RP-HPLC, using a
semi-preparative column (Shiseido C18, 250 × 10 mm, 5 μm)
under isocratic elution with different concentrations of the mobile
phase: 53% (v/v) acetonitrile in water [containing 0.1% (v/v) TFA]
for Protonectarina-MP-NH2; and 38% (v/v) acetonitrile in water
[containing 0.1% (v/v) TFA] for Protonectarina-MP-OH. The elution
was monitored at 214 nm with a UV-DAD detector (Shimadzu,
mod. SPD-M10A). The homogeneity and correct sequences of the syn-
thetic peptides were assessed using a gas-phase sequencer, PPSQ-21A
(Shimadzu), based on automated Edman degradation chemistry and
ESI-MS analysis.2.2. Mast cell degranulation
Degranulation was determined by measuring the release of the
granule marker, β-D-glucosaminidase, which co-localizes with hista-
mine, as previously described [22].Mast cells were obtained by the peri-
toneal washing of female adult Wistar rats. Mast cells were washed
three times by re-suspension and centrifugation in a mast cell medium
[150 mM NaCl (Merck), 4 mM KCl (Merck), 4 mM NaH2PO4 (Synth),
3 mM KH2PO4 (Synth), 5 mM glucose (Synth), 15 μM BSA (Sigma),
2 mM CaCl2 (Merck), and 50 μL Liquemine (5000 UI/0.250 mL)
(Roche)]. The cells were incubated with various peptide concentrations
for 15 min at 37 °C, and, following centrifugation, the supernatants
were assayed for β-D-glucosaminidase activity. Brieﬂy, 50 μL of sub-
strate (5mMp-nitrophenyl-N-acetyl-β-D-glucosaminidine in 0.2 M cit-
rate, pH 4.5) and 50 μL of medium samples were incubated in 96-well
plates for 6 h at 37 °C to yield the chromophore p-nitrophenol. After in-
cubation, 50 μL of the previous solution was added to 150 μL of 0.2 M
Tris, and the absorbance was measured at 405 nm. The values were
expressed as the percentage of total β-D-glucosaminidase activity
from rat mast cell suspensions, determined in lysed mast cells in the
presence of 0.1% (v/v) Triton X-100 (considered to be the 100% refer-
ence point). The results were compared to the activities measured for
the standardmast cell degranulating peptide HR2 (Sigma). The cell sus-
pensions in the absence of any peptide were used as negative controls.
The results are expressed as the means ± SD of ﬁve experiments.
2.3. Mast cell lysis
Mast cell lysiswas assayed bymeasuring the leakage of lactate dehy-
drogenase (LDH) from the mast cell cytoplasm; the LDH assay was per-
formed as previously described [23]. The cells utilized in this assaywere
the same as those used in mast cell degranulation assay, described
above. LDH activitywas assayed by using theUV-LDHAssay Kit (Biobras
Diagnostics); 20 μL of each supernatant was pre-incubated with 800 μL
of LDH buffer (50 mM Tris pH 7.4, containing 1.2 mM pyruvate and
5 mM EDTA) for 5 min, at 37 °C. The reaction was initiated by the addi-
tion of 200 μL of LDH substrate (0.15 mMNADH); the kinetics of NADH
consumption were monitored by recording the decrease in absorbance
at 340 nmover 3min (ΔA340) at 37 °C. The results were initially calcu-
lated as catalytic units (μmolNADHmin−1 at 37 °C and pH7.4) and then
converted into relative activity, compared to the total LDH activity of rat
mast cells lysed in the presence of 0.1% (v/v) Triton X-100 (considered
to be the 100% reference point). The results are expressed as the
means ± SD of ﬁve experiments.
2.4. Hemolysis
Five hundredmicroliters of washed rat red blood cells (WRRBC)was
suspended in 50 mL of physiological saline solution [0.9% (w/v) NaCl].
Ninety microliters of this suspension was incubated with 10 μL of pep-
tide solution at different concentrations, at 37 °C for 2 h. The samples
were then centrifuged, and the supernatants were collected; the absor-
bance values of the supernatants were measured at 540 nm. The absor-
bancemeasured from lysedWRRBC in thepresence of 1% (v/v) TritonX-
100was considered to be 100%. The results are expressed as themeans±
SD of ﬁve experiments.
2.5. Antimicrobial activity
Theminimal inhibitory concentration (MIC) of the peptides was de-
termined based on themethods previously described byMeletiadis and
colleagues [24]. The following microorganisms were used: Staphylococ-
cus aureus (CCT 2580), Bacillus cereus (ATCC 11778), Escherichia coli
(CCT 1457), and Pseudomonas aeruginosa (ATCC 15422). The experi-
ment was performed in 96-well plates. Bacterial cells were suspended
in sterile culture medium; the inoculum size was 1 × 104 cells/mL in
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scale. From this culture, 50 μL was spread onto a microplate previously
containing 50 μL of Müller–Hinton broth, resulting in a ﬁnal cell density
of 1.5 × 103 cells/mL. Cells were incubated at 37 °C for 18 h in the pres-
ence of 100 μL of each peptide solution, at concentrations ranging from
0.24 to 500 μg/mL. After incubation, 10 μL of a triphenyltetrazolium
chloride (TTC) (Mallinckrodt) solution (ﬁnal concentration 0.05% w/v)
was added to each plate. The plates were incubated at 37 °C for 24 h,
and, after incubation, 20 μL of a triphenyltetrazolium chloride solution
(TTC) 0.5% (w/v) was added. The plates were then incubated for an
additional period of 2 h at 37 °C. The minimal inhibitory concentra-
tion was deﬁned as the concentration at which the dye level was
not reduced; oxytetracycline, at concentrations ranging from 0.24 to
500 μg/mL, was used as a control. The results are expressed as the
means ± SD of ﬁve experiments.
2.6. Liposome preparation
Homogeneous ﬁlms were made with pure egg L-α-phosphatidyl-
choline (PC) or a 70:30molar ratio mixture of PC and egg L-α-phospha-
tidyl-DL-glycerol (PG), both supplied by Sigma-Aldrich. The ﬁlms were
obtained by dissolving the phospholipids in a small volume of chloro-
form (1–2 mL), evaporated under N2 ﬂux in round bottom ﬂasks, and
completely dried under vacuum for at least 3 h. These ﬁlms were hy-
drated with ultrapure water at a ﬁnal phospholipid concentration of
5 mM for H/D exchange mass spectrometry analysis; or with 5 mM
Tris/H3BO3 buffer, containing 0.5 mM EDTA and 150 mM NaF, pH 7.5,
for CD spectroscopy analysis; or with 10mMTris/HCl buffer, containing
either 25 mM carboxyﬂuorescein (CF) for leakage experiments or
150 mM NaCl for ﬂuorescence spectroscopy. The suspension was soni-
cated with a titanium-tipped soniﬁer (40 W), under N2 ﬂux, in an ice/
water bath for 50 min (or until clear) to produce small unilamellar ves-
icles (SUVs). Titanium debris was removed by centrifugation. Large
unilamellar vesicles (LUVs), used in dye release experiments and tryp-
tophan ﬂuorescence spectroscopy, were obtained by two extrusion
steps using an Avanti Mini-Extruder (Alabaster, AL, USA) and double-
stacked polycarbonate membranes (Nuclepore Track-etch Membrane,
Whatman); the suspension was passed 6 times through 0.4 μmmem-
branes and then 11 times through 0.1 μm membranes. For the dye-
entrapped LUVs, free dye was separated by gel ﬁltration on a Sephadex
G25M column (Amersham Biosciences). LUVs were usedwithin 48 h of
preparation. SUVs were used immediately following preparation. The
lipid concentration was determined by phosphorus analysis [25]. Laser
light scattering measurements, with a Zeta Sizer Nano NS-90 (Malvern
Instruments), revealed homodisperse LUVs in suspension, with an
average diameter of 105.0 ± 0.2 nm, among several preparations.
2.7. Circular Dichroism (CD) measurements
CD spectra were obtained using a 20 μMpeptide concentration in
different environments: in water; in Tris/H3BO3 buffer, containing
0.5 mM EDTA and 150 mM NaF, pH 7.5; in 40% (v/v) 2,2,2-
triﬂuoroethanol (TFE)/bi-distilled water; in sodium dodecyl sulfate
solutions (SDS), above and below the critical micellar concentration
(CMC) (8 mM and 165 μM, respectively); in 100 μM PC; and in
100 μM PCPG SUVs. CD spectra were recorded from 260 to 190 nm
or 200 nmwith a Jasco-815 spectropolarimeter (JASCO International
Co. Ltd., Tokyo, Japan), which was routinely calibrated at 290.5 nm
using d-10-camphorsulfonic acid solution. Spectra were acquired at
25 °C using 0.5 cm path length cell and averaged over nine scans, at a
scan speed of 20 nm/min, bandwidth of 1.0 nm, 0.5 s response and
0.1 nm resolution. Following baseline correction, the observed elliptici-
ty, θ (mdeg) was converted to mean residue ellipticity [Θ] (degcm2/
dmol) using the relationship: [Θ] = 100 h/(lcn); where l is the path
length in centimeters, c is the peptide millimolar concentration, and n
is the number of peptide bonds. Assuming a two-state model, theobservedmean residue ellipticity at 222 nm ([Θ]222 obs) was converted
into an α-helix fraction (fα), using the method proposed by Rohl and
Baldwin [26].
2.8. Molecular modeling
The modeling procedure began with an alignment of the target
peptide sequence with Mastoparan-X (PDB ID: 2CZP), a related pep-
tide of known three-dimensional (3D) structure, as a template [27].
Homologous structures for the peptides Protonectarina-MP-NH2
and Protonectarina-MP-OH, among known structural templates in
the PDB (Protein Data Bank), were identiﬁed using BLASTP [28,29].
This alignment was formatted to be the input for the program MOD-
ELER. The output is a 3D model for each target sequence containing
all main-chain and side-chain non-hydrogen atoms. Several slightly
different models can be calculated by varying the initial structure.
To build the models, MODELLER 8 v.2 was used [30]. For each pep-
tide, a total of 1000 models were created, and the stereochemical
quality of the models was assessed by the program PROCHECK [31].
The ﬁnal models were selectedwith 100% residues in favored regions
of the Ramachandran plot, with the best values for the overall G fac-
tor and the lower values of energy minimization. The images were
constructed using the graphics programs MolMol [32] and VMD
1.8.6 [33].
2.9. Dye leakage
An aliquot of the LUV suspensionwas injected into a 1 cmquartz cell,
containing magnetically stirred peptide solutions in Tris/HCl buffer
(10 mM, EDTA 1 mM and 150 mM NaCl), at peptide concentrations
ranging from 0.5 to 45 μM, for a ﬁnal volume of 1.2 mL; suspensions
were added according to the permeabilizing efﬁciency, to achieve ap-
proximately 100% leakage within 20–30 min of contact time. The re-
lease of carboxyﬂuorescein (CF) from the vesicles was ﬂuorometrically
monitored using an ISS PC1 spectroﬂuorometer (Urbana Champaign,
IL, USA), in which the emission was set at 520 nm and the slit width
was set at 0.5 nm (excited at 490 nm, 1 nm slit width). To determine
the decrease in self-quenching at 25 °C, the percentage of dye leakage
was calculated after regular time intervals, with the equation: percent-
age of leakage = 100 × (F− F0) / (F100− F0); where F is the observed
ﬂuorescence intensity; and F0 and F100 correspond, respectively, to the
ﬂuorescence intensities in the absence of peptides and to 100% leakage,
as determined by the addition of 20 μL of a 10% Triton X-100 solution.
The results are expressed as the means ± SD of three experiments.
2.10. ESI mass spectrometry
Mass spectrometric analyses were performed in a triple quadrupole
mass spectrometer (Micromass, Mod. Quattro II). The experimental
protocol was based on previously described methods [34] and adapted
to the present investigation. The mass spectrometer was outﬁtted
with a standard probe electrospray (ESI, Micromass, Altrincham, UK).
The samples were injected into the electrospray transport solvent
with a microsyringe (250 μL) coupled to a microinfusion pump (KD
Scientiﬁc) at a ﬂow rate of 4 μL/min. The mass spectrometer was cali-
brated with intact horse heart myoglobin and its typical cone-voltage
induced fragments to operate at a resolution of 4000. The samples
were analyzed by positive electrospray ionization (ESI) using typical
conditions: a capillary voltage of 3.5 kV; a cone-voltage of 52 V; a
desolvation gas temperature of 80 °C; and ﬂow of nebulizer gas (nitro-
gen) of approximately 20 L/h and drying gas (nitrogen) at 200 L/h. The
ESI mass spectra were obtained in the continuous acquisition mode,
scanning from m/z 50 to 4000 at a scan time of 10 s. The data were
acquired and treated using MassLynx software (Micromass). Typical
conditions used to perform the CID MS experiments were: argon as
the collision gas; a capillary voltage of 1.78 kV; a cone voltage of
Fig. 1. Degranulation activity in rat peritoneal mast cells. The activity was determined by
measuring the release of the granule marker, β-D-glucosaminidase, which co-localizes
with histamine and the values for β-D-glucosaminidase released in the medium were
expressed in the percentage of total β-D-glucosaminidase. Values are mean± SD (n=5).
Fig. 3. Hemolytic activity in washed rat red blood cells (WRRBC). The absorbance mea-
sured at 540 nm from lysedWRRBC in the presence of 1% (v/v) Triton X-100 was consid-
ered as 100%. Values are mean ± SD (n= 5).
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3 × 10−3 mBar; and a desolvation gas temperature of 80 °C. Peptide
sequences were manually assigned from the ESI-MS/MS product ion
mass spectra.
2.11. Hydrogen/deuterium exchange of free peptides and their interactive
forms with liposomes
The H/D exchange assays between free peptides and peptides
interacting with liposomes were performed as described previously
[19]. LUVs in the presence or absence of peptides were pre-incubated
for times ranging from 1 to 60min at room temperature beforemeasur-
ing H/D exchange. The suspensions of liposomes in the presence of
peptides were prepared for H/D exchange monitoring as described
above, except for the replacement of bidistilled water with 99% (v/v)
D2O (Cambridge Isotopes Laboratories, Inc.). The free peptide solution
was prepared for H/D exchange by adding 6 μL of peptide solution
(1 μg/μL) to either 22 μL bidistilled water or liposome suspension and
adding 50 μL 99% (v/v) D2O following the liposome pre-incubation.
The H/D exchange was allowed to proceed for 30 s and was then
quenched by adjusting thepH to 2.5 by the addition of 2 μL of 88% formic
acid and cooling to 0 °C. The solution of free peptides or the liposomes/
peptide suspension was introduced into the mass spectrometer at a
ﬂow of 4 μL/min with a microperfusion pump (KD Scientiﬁc). Spectra
were continuously acquired over 3 min by direct injection of theFig. 2.Delivering of LDH activity from rat peritoneal mast cells to the incubation medium.
The results were shown as relative activity by using the total LDH activity contents of rat
mast cells lysed in the presence of 0.1% (v/v) Triton X-100 (considered as 100%). Results
are expressed as mean ± SD (n= 5).samples into the ionization source system. Mass spectrometric mea-
surements were started as quickly as possible (the dead timewas ap-
proximately 90 s) and analyses were performed in MS and MS/MS
modes. Taking into account both the time of incubation between
the free peptide/proteoliposomes and the dead time of the experiment,
the ﬁrst time point of each mass spectrometry measurement was
acquired at 2 min and lasted until 3 min. Each H/D exchange reaction
was performed three times for each condition, and the tandem mass
spectra were individually acquired for each replicate experiment. The
mass-to-charge values of all ions of interest from each spectrum were
used to calculate the rate values, with their respective standard devia-
tions, and for the calculation of deuterium incorporation into the
peptide.
2.12. Determination of the scrambling factors for deuteron positions
The scrambling factor (SF) was calculated according to Eq. (1), as
previously described [19]:
SF ¼
XN
i
Δ Dst−Dcoð Þj j−
XN
i
Δ Dst−Dexð Þj j
XN
i
Δ Dst−Dcoð Þj j
ð1Þ
where: Δ (Dst− Dco)— is the deviation between the deuterium content
per fragment-ion, considering two virtual opposite situations: full deu-
teron scrambling and no scrambling;Δ (Dst−Dex)— is the deviation be-
tween the deuterium content per fragment-ion in the virtual full
deuteron scrambling and the experimental values obtained for each
set of the experimental conditions; i— represents the individual subse-
quent fragment-ions; and N— represents the total number of fragmentTable 1
Minimal inhibitory concentration (MIC) of the peptides Protonectarina-MP-NH2 and
Protonectarina-MP-OH compared to other wasp venom antimicrobial peptides.
Peptides Minimal inhibitory concentration (μg/mL)
Gram-negative Gram-positive
E. coli P. aeruginosa S. aureus B. cereus
Protonectarina-MP-OH 62.5 N500.0 250.0 62.0
Protonectarina-MP-NH2 7.8 62.5 15.6 7.8
Oxytetracycline 1.0 3.9 b0.2 1.0
Anoplin 50.0 20.0 5.0 20.0
Crabroline 150.0 N500.0 N500.0 75.0
EMP-AF 50.0 20.0 5.0 N500.0
Mastoparan-M 12.5 12.5 6.2 N500.0
Fig. 4.CD spectra of (A) Protonectarina-MP-NH2 and (B) Protonectarina-MP-OH obtained at 20 μM, at 25 °C, in the presence ofwater, 8mMSDS and 40% (v/v) TFE. No smoothing has been
applied.
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spectra.3. Results
3.1. Biological activities
Protonectarina-MP-NH2 and Protonectarina-MP-OH were analyzed
in assays for mast cell degranulation, the release of LDH activity from
mast cells, hemolysis, chemotaxis of PMNLs and antimicrobial activities.
Fig. 1 shows the results of rat peritonealmast cell degranulation for both
forms of Protonectarina-MP and for the standard peptide (HRII). The re-
sults revealed that Protonectarina-MP-NH2 is a potent mast cell
degranulating peptide, presenting degranulation activity (ED50 =
8 × 10−5 M) slightly higher than the standard peptide HRII (ED50 =
20 × 10−5 M). However, Protonectarina-MP-OH presented a reduced
degranulation activity, even at high concentrations. Thus, it was not
possible to determine the ED50 value for Protonectarina-MP-OH.
The lysis of rat peritoneal mast cells was monitored by measure-
ments of LDH activity delivered to the incubation medium. This pro-
cedure was performed to determine whether the peptides could
disturb the structure of the mast cell membrane; the results of this
assay are shown in Fig. 2. Protonectarina-MP-NH2 presented an ele-
vated level of activity (ED50 = 6 × 10−5 M), which was higher thanFig. 5. CD spectra of (A) Protonectarina-MP-NH2 and (B) Protonectarina-MP-OH obtained at 20
has been applied.that presented by the standard peptide HR-II (ED50 = 20 × 10−5 M),
while Protonectarina-MP-OH presented no activity.
Hemolysis of rat erythrocytes was also examined for both forms of
Protonectarina-MP, and the results are shown in Fig. 3. Mellitin was
used as the standard peptide, presenting high hemolytic activity
(ED50= 6 × 10−7 M); Protonectarina-MP-OH presented no hemoly-
sis, while Protonectarina-MP-NH2 presented a reduced level of he-
molysis (ED50 = 2 × 10−4 M).
The antimicrobial activities of both forms of Protonectarina-MP
were examined and compared to the previously reported activities of
peptides derived from wasp venoms; these results are summarized
in Table 1. Protonectarina-MP-NH2 presented a potent antimicrobial
activity against both Gram-positive and Gram-negative bacteria,
while Protonectarina-MP-OH presented a much more reduced anti-
microbial activity. The antimicrobial activity of Protonectarina-MP-
NH2 was similar to that observed for Anoplin, in relation to Gram-
positive and Gram-negative bacteria, and to mastoparan-M, in rela-
tion to the Gram-positive bacteria [5].3.2. Structure investigations
The secondary structures of Protonectarina-MP-NH2 and
Protonectarina-MP-OH were investigated by CD spectroscopy in
different environments (Figs. 4 and 5). The spectra of Protonectarina-μM, 25 °C in the presence of buffer-Tris and SUVsmade with PC and PCPG. No smoothing
Table 2
α-Helix fraction (fα) of the Protonectarina-MP-NH2 and Protonectarina-MP-OH in differ-
ent environments.
Protonectarina-MP-NH2 Protonectarina-MP-OH
[Θ222] fα [Θ222] fα
Water −4330 0.15 −2490 0.07
8 mM SDS −12,400 0.39 −5360 0.16
40% TFE −14,530 0.47 −5430 0.16
Tris buffer −4970 0.15 −2190 0.06
PC −7980 0.25 −2490 0.07
PCPG −12,460 0.39 −6700 0.20
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helical tendencies. The dichroic band at 198 nm, which is characteristic
of unordered structures, was deviated to 204 nm, while a small dichroic
band appeared near 222 nm. In the same environments, the spectra of
Protonectarina-MP-OH were characteristic of unordered structures
(Fig. 4B). The spectra of Protonectarina-MP-NH2 and Protonectarina-
MP-OH in the presence of 40% (v/v) TFE or in 8 mM SDS (Fig. 4A and
B) showed negative dichroic bands at 208 and 222 nm, consistent
with the induction of α-helical conformations in these media. Table 2
presents the molar ellipticity ([Θ222]) and the fraction of α-helices,
calculated according to the two-state model for both peptides in these
environments. Both peptides were clearly different in the total content
of helical structures. In the presence of zwitterionic PC or anionic PCPG
vesicles, the spectra of both peptides also differed in relation to the con-
tent of helical structures (Fig. 5A and B).
The induction of a higher helical content for the amidated peptide in
relation to the form presenting acidic C-terminus in the presence of
zwitterionic vesicles reﬂects a more efﬁcient interaction between the
amidated peptide and the membrane, and it is well correlated with
the increased mast cell degranulation, hemolysis and LDH delivery.
Additionally, the increased helical content of the amidated peptide in
the presence of anionic vesicles when compared to its acidic form is
well correlated with its lower MIC values (Table 1). These resultsFig. 6. Structural models of Protonectarina-MP-NH2 (A and B) and Protonectarina-MP-OH (C
chains shown, in both ribbon representation (A and C), and as charge surface representation (B
drophobic in white.indicated that C-terminal amidation is fundamental for peptide back-
bone structuration, i.e., for the stabilization of the secondary structure
in α-helical conformations.
The secondary structures of Protonectarina-MP-NH2 and
Protonectarina-MP-OH were also analyzed by molecular modeling;
1000 models were generated and validated through the analysis of
the structure by the Procheck program [31]. This analysis considered
the Ramachandran plot and values of the overall G-factor. Ideally, the
value of this factor should be above−0.5. Fig. 6A and C shows the mo-
lecularmodels of these peptides as ribbon representations, while Fig. 6B
and D represents the charged surface distribution for each peptide. The
G-factor values for both models were 0.26 for Protonectarina-MP-NH2
and 0.37 for Protonectarina-MP-OH. In both models, all the residues
were in the most favored regions of the Ramachandran plot, with
eleven residues in the α-helical region and only a single residue at the
β-sheet region (result not shown). The residues at the amino- and
carboxyl-termini were not considered because they can be localized in
any region of the diagram.3.3. Investigation of the interactions with membrane-mimetic vesicles
The lytic activity of both forms of Protonectarina-MPwas investigat-
ed by analyzing the leakage of carboxyﬂuorescein from PC and PCPG
vesicles induced by each peptide. Dose–response curves revealed sig-
moid proﬁles for Protonectarina-MP-NH2 in the presence of either PC
or PCPG vesicles, while Protonectarina-MP-OH presented the sigmoid
proﬁle only in the presence of PCPG vesicles, as shown Fig. 7A and B,
respectively. The dose–response curves suggested that the peptidemol-
ecules bind and accumulate on the external surface of vesicles and cell
membranes until a critical threshold concentration is reached (P/L
molar ratio) (Table 3). Further peptide accumulation caused intense
leakage. Fig. 7A shows the remarkable differences in the lytic activity
on zwitterionic PC vesicles between amidated and carboxylated forms
of Protonectarina-MP. A critical P/L concentration below 0.45 could
not be determined, indicating that the amidated form wasand D). Two different views of closest-to-the-mean structure of residues 1–14 with side
and D): negative residues are shown in red, positive in blue, hydrophilic in green and hy-
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Fig. 7. Dose–response curves showing the percentage of CF leakage after 5 contact times, at 25 °C.
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and had stronger peptide–membrane interactions. These results
are in agreement with the higher hemolytic character of the
amidated form (Fig. 3) and with its higher helical content in PC ves-
icles (Fig. 5 and Table 2). Protonectarina-MP-NH2 was also more
lytic than Protonectarina-MP-OH in anionic PCPG vesicles. Fig. 7B
shows that the carboxylated peptide was more selective towards the
anionic environment.
To better understand the peptide–membrane interactions, the
measurement of H/D exchange between peptides interacting with
membrane-mimetic systems was used, monitored by ESI-mass spec-
trometry, as previously reported for other mastoparans [19]. This
technique permits a site-speciﬁc determination of the deuteron
positions in peptide–membrane proteoliposome systems, indicating
which amino acid residues of the peptide chain are in the inner core
of the membrane as well as which residues are interacting with the
outside medium.
Fig. 8A shows the CID spectrum of Protonectarina-MP-NH2 soluble
in water and Fig. 8B shows the CID spectrum of the peptide soluble in
40% (v/v) D2O. Fig. 8C to H shows the spectra of H/D exchanges in 40%
(v/v) D2O at different times of incubation, in a time course experiment
in the presence of the zwitterionicmembrane of PC. The spectra showed
that the number of deuterons incorporated into the peptide chain
varied according to time.
The residues Leu6, Leu7, Asp8, Ala9 and Ala10 changed their deutera-
tion state depending on the time of incubation; meanwhile, lle1, Asn2,
Lys4, Ala5, Lys11, Lys12, Val13 and Leu-NH2 at the C-terminus remained
deuterated the entire course of incubation, in the presence of PC vesi-
cles. The residue Trp3 remained embedded into the membrane most
of the incubation time, preventing to be deuterated. Considering the
large sizes of the ﬁgures showing the tandem mass spectra of the
peptides in the presence of PC and PCPG vesicles, the CID spectra of
Protonectarina-MP-NH2, in the presence of PCPG vesicles, and theTable 3
Critical P/L molar ratios and EC50 (peptide concentration to reach 50% CF leakage in 5′)
determined for the peptides Protonectarina-MP-NH2 and Protonectarina-MP-OH from
the leakage dose–response curves, in PC and PCPG vesicles.
Critical P/L ratio EC50 (μM)
PC PCPG PC PCPG
Protonectarina-MP-OH – 0.036 – 5.0
Protonectarina-MP-NH2 0.0085 0.026 2.0 4.3CID spectra of Protonectarina-MP-OH, in the presence of PC and
PCPG vesicles, are shown in the supplemental information (Figs. S1
to S3).
Fig. S1 shows the spectra of theH/D exchange of Protonectarina-MP-
NH2 in water (Fig. S1A), in the presence of PCPG vesicles and 40% (v/v)
D2O (Fig. S2B), at different incubation times from a time course incuba-
tion (Fig. S1C toH). The spectra showed that the incorporation from 8 to
11 deuterons occurred between 1 and 60 min incubation; under these
conditions all residues of the peptide chain altered their H/D exchange
depending on the time of incubation.
Fig. S2 shows the spectra of the H/D exchange of Protonectarina-
MP-OH in water (Fig. S2A), in the presence of PC vesicles and 40% (v/v)
D2O (Fig. S2B), at different incubation times from a time course incuba-
tion (Fig. S2C to H). Under these conditions the only residues that
became deuterated during all incubation time were the Ile and Leu
from N- and C-termini, respectively; all the other residues altered
their deuteration condition, depending on the time of incubation, in
the presence of PCPG vesicles.
Fig. S3 shows the spectra of theH/D exchange of Protonectarina-MP-
OH in water (Fig. S3A), in the presence of PCPG vesicles and 40% (v/v)
D2O (Fig. S3B), at different incubation times from a time course incuba-
tion (Fig. S3C to H). The spectra showed that the incorporation of 11 to
13 deuterons from 1 to 60 min incubation, where most of the amino
acid residues from peptide sequence altered their H/D exchange
depending on the time of incubation.
Demmers et al. [20] suggested that the extent of intramolecular hy-
drogen scrambling is strongly inﬂuenced by experimental factors, such
as the exact amino acid sequence of thepeptide, thenature of the charge
carrier, and, most likely, by the gas-phase structure of the peptide ion.
Some studies have reported that hydrogen mobility within peptide
ions is sufﬁciently rapid to scramble their position, even prior to their
collision during mass spectrometric analysis [35]. As H/D exchange in
combination with mass spectrometry analysis under CID conditions is
used more frequently for the structural and conformational investiga-
tions of proteins and peptides, it is very important to observe and to
minimize the effects of deuterium scrambling in the results obtained
through this technique. De Souza and Palma [19] developed a method
to validate the results obtained from H/D exchange combined with
CIDmass spectrometry. Thus, the scrambling factor is a number deﬁned
between 0 (indicating no scrambling) and 1 (representing a statewith a
statistical distribution of all deuterium atoms). Table 4 shows the
scrambling factors determined for the positions of deuterons in the
MS/MS spectra for Protonectarina-MP-NH2 and Protonectarina-MP-
OH, in the presence of PC and PCPG vesicles (Figs. 8 and S1 to S3).
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results and the proposed models of peptide–membrane interactions
are reliable.
Based on the results obtained from H/D exchange and mass spec-
trometry assays reported above, it was possible to propose a peptide/
membrane interaction for each experimental condition assayed. Fig. 9
shows some snapshots of the time course incubation experiment, in
which somemodels of interactionpeptide–membrane for bothpeptides
in the presence of PC and PCPG vesicle membranes are proposed.
Because the measurement of H/D exchange was performed for the
amide hydrogen of each peptide bond, the positions assigned as
“deuterated” in the mass spectra represent the orientation of the
α-carbon backbone of each amino acid residue to the external mem-
brane surface; the “non-deuterated” position corresponds with the
embedding of the α-carbon backbone in the membrane core. Thus,
the deuterated amino acid residues were positioned in the external
membrane surface (assigned to the white region in the scheme
shown in Fig. 9). However, the non-deuterated amino acid residues
were interacting with the core of the membranes, and, therefore,
were assigned to the gray region of the scheme shown in Fig. 9.4. Discussion
Mastoparans are polycationic peptides from the venoms of social
wasps, presenting amphipathic helical structures capable of inducing
mast cell degranulation and/or the lysis of mast cell membranes, hemo-
lysis and sometimes antimicrobial actions [36]. The degranulating activ-
ity appears to be related to the activation of G-protein coupled receptors
in the mast cells, while the other activities mentioned above are as-
cribed to the ability of the peptides to interact with the cell membrane
surface via the positively charged side-chains of their amphipathic α-
helical structures [37].
The increased biological activities of polycationic peptides appear to
be associated with the amidation of their C-terminal residues. There are
studies reporting higher activities of amidated mastoparans compared
with their acidic counterparts [38]; however, the precise mechanism
of action for these peptides is not known yet. It is believed that the bio-
logical actions that depend on the direct interactions between the pep-
tides and the lipid components of cell membranes (mast cell lysis,
hemolysis and antibiosis) occur through either the barrel stave or the
carpet-like mechanisms [39,40]. It was demonstrated that the reduced
activity of the acidic form of mastoparans occurs not only due to the
reduction of the net positive charge of these peptides, but also due
to a structural destabilization of the amphipathic α-helix, which
also affects their direct interaction with cell membranes [15].
Despite the importance of these studies, little extensive investiga-
tion has been performed focusing on the structure/activity relationship
of mastoparan peptides. Structural and functional studies have always
been isolated from each other; some functional investigations only
assayed mast cell degranulation and/or leukocytes chemotaxis, which
are mostly dependent on peptide–receptor (GPCRs) interaction [41,
42]. Meanwhile, other studies have focused only on hemolytic action
and/or antibiosis, which are dependent on peptide–phospholipid inter-
action [43,44], without investigatingmast cell degranulation and PMNL
chemotaxis. In addition to the raised concerns, most of these experi-
mentswere performed using different peptide sequences, making it dif-
ﬁcult to make generalized observations.Fig. 8. CID MS spectra of Protonectarina-MP-NH2, acquired under continuous infusion of the pe
mass spectrometer. Each spectrum represents the combination of scans within 1 min of data ac
D2O (molecular ion at m/z 1582.0 as [M+H]+); (B–H) peptide soluble in the presence of 40% D
H/D exchange; peptide as proteoliposome in PC vesicles, in the presence of 40% D2O (v/v) incu
60min, and after quenching theH/D exchange (molecular ion atm/z 1593.0 as [M+H]+, 1591.
[M + H]+, respectively). The mass differences between the consecutive bn fragment-ions and
assigned under the symbols of some amino acid residues correspond to the location of deuteroThus, the mastoparan peptide Protonectarina-MP was selected as a
model for the investigation of the structure/activity relationship, using
peptides with either an acidic (Protonectarina-MP-OH) or an amidated
(Protonectarina-MP-NH2) C-terminus. The peptides were manually
synthesized in solid phase and puriﬁed using RP-HPLC under isocratic
elution, and their purities were checked by ESI/MS analysis. Simulations
of the secondary structures of each peptide were performed using
molecular modeling by homology. Both models were considered
stereochemically possible using the validation tools, Ramachandran
plots and G-factors. Because these models were built based on a static
helical template (Mastoparan-X; PDB ID: 2CZP), they corresponded at
this level of consideration to helical molecules. Fig. 6 shows themodels,
where the amphiphatic character of both molecules is clear, i.e., the
peptides have a predominantly hydrophobic surface, distinct from the
hydrophilic ones.
Experimental data from CD spectroscopy inmembrane-mimetic en-
vironments conﬁrmed the helical structure of both Protonectarina-MP
peptides in anionic PCPG vesicles, while in PC vesicles, only the
amidated form assumed a helical structure. The peptide presenting a
higher content of secondary structures (Protonectarina-MP-NH2)
appeared to interact more efﬁciently with membrane-mimetic systems
than the form with a reduced level of secondary structure organization
(Protonectarina-MP-OH). Experiments measuring dye leakage con-
ﬁrmed that Protonectarina-MP peptides may target the phospholipid
matrix of either anionic or zwitterionic cell membranes, but their lytic
activity appears to be inﬂuenced by the ionic character of the bilayer.
Protonectarina-MP-OH presented more intense activity on anionic
bilayers, while Protonectarina-MP-NH2 was much less selective since
it seems to interact both with zwitterionic and anionic membranes.
The threshold P/L ratio and the leakage efﬁciency of these peptide–
membrane interactions were found to be dependent on the vesicle
surface charge density and on the net charge of the peptides.
Considering that the mode of interaction between the mastoparan
peptides and the membranes is not well known, it is important to un-
derstand the effect of the amidation of the C-terminus of mastoparans
on the peptide–membrane interactions. To investigate these interac-
tions, a previously reported experimental protocol was applied in
which the nascent peptide–membrane interactions could be monitored
by examining peptides interacting with lipid vesicles. The peptide/vesi-
clemixtureswere incubated in the presence of D2O under experimental
conditions that permitted the continuous monitoring of the H/D
exchange of the amide protons from the solvent-exposed peptide
bonds (positioned outside membrane), by ESI-MS andMS/MS analyses.
In this protocol, the backbone amide sites embedded in the membrane
were protected from the H/D exchange [19]. The protocol used is sensi-
tive and powerful enough to be used as tool for investigating the archi-
tecture of short, linear, α-helical peptides at the membrane–water
interface of vesicles, while they are interacting with the membranes
[19]. In this type of protocol, some extension of intramolecular deuteri-
um scrambling may occur, which could potentially affect the precision
of information regarding the correct positioning of the amide protons
in the peptide backbone exposed to the solvent. To evaluate the reliabil-
ity of each reported deuterium location at the peptide bonds, and to val-
idate the models of the global positioning of the α-carbon backbone of
the peptides in relation to the external medium and membrane core
of the vesicles when interacting with PC and PCPG vesicles, the scram-
bling factors for all of the CID spectra obtained for each incubation
condition were determined. This factor is a number between 0 (noptide solution or liposome suspension in the presence of peptide (in PC vesicles) into the
quisition at different incubation conditions: (A) peptide soluble in water in the absence of
2O (v/v) (molecular ion atm/z 1593.0 as [M+H]+) at different times, after quenching the
bated during (B) 1 min, (C) 3 min, (D) 5 min, (E) 10 min, (F) 15 min, (G) 30 min and (H)
0 as [M+H]+, 1592.0 as [M+H]+, 1546.0 as [M+H]+, 1595.0 as [M+H]+ and1593.0 as
their correspondence to the deduced amino acid sequences are shown. The black spots
ns at speciﬁc amide hydrogens.
Table 4
Scrambling factors determined for the positions of deuterons in the tandemmass spectra
acquired for the peptides Protonectarina-MP-NH2 and Protonectarina-MP-OH under in-
teraction with PC and PCPG vesicles.
Time (min) Protonectarina-
MP-NH2
Protonectarina-
MP-OH
PC PCPG PC PCPG
1 0.25 0.25 0.00 0.05
3 0.35 0.38 0.23 0.08
5 0.38 0.37 0.27 0.28
10 0.32 0.10 0.20 0.30
15 0.28 0.08 0.14 0.23
30 0.31 0.32 0.07 0.17
60 0.10 0.27 0.35 0.29
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shows that the scrambling factors changed from 0.00 to 0.38, indicating
that the results from the present investigation and the proposedmodels
of peptide–membrane interactions are reliable (Fig. 9).
The results summarized in Fig. 9 show that under the conditions
assayed, both peptides interacted in parallel to the membrane surface
and were not fully internalized into the lipid layer. The α-carbon back-
bone of both peptides formed a twisted structure, in which some re-
gions became exposed to the solvent outside of the membrane, while
other regions of this backbone were internalized in the membrane.
The total number of amino acid residues contained in the regions em-
bedded in the membrane provides us with information regarding how
strong the peptide–membrane interaction is. Thus, it is clear that both
peptides interacted better with the anionic vesicles (PCPG) than with
the zwitterionic vesicles (PC), most likely due to the stabilization of
the supra-molecular structure between the peptide and the membrane
when the negative charges of the anionic membranes neutralize the
positive charges of the peptides. Protonectarina-MP-NH2 interacted
better with both types of the membranes than Protonectarina-MP-OH.
Thus, the peptide with an amidated C-terminus embedded from 3 to 5
residues into the PCmembrane (with a rate value of 3.6), while the pep-
tide with an acidic C-terminus embedded from 0 to 3 residues (with a
rate value of 1.4) during the 60 min incubation. Protonectarina-MP-
NH2 interacted with the anionic membranes (PCPG), embedding from
3 to 5 residues into the membrane (with rate value of 4.7), while
Protonectarina-MP-OH embedded from 1 to 3 residues (with a rate
value of 2.7).
Some interesting features observed in these experiments were as
follows: i) the N-terminus of both peptides always remained positioned
outside of the membrane during most of the incubation time for both
forms of the peptide; ii) the C-terminus (including the neighbor region)
remained exposed to the outside membrane most of the time, for both
forms of the peptide, except near the 10 min incubation time for
Protonectarina-MP-NH2 with PCPG vesicles; and iii) amino acid resi-
dues presenting hydrophobic side-chains, such as the residue of Trp,
became embedded into the membrane from 3 min of incubation until
the end of the experiment for Protonectarina-MP-NH2; this occurred
only a few times in the incubations of Protonectarina-MP-OH with
both types of vesicles.
The H/D exchange experiments were performed with [P]/[L] of 1/
100, i.e., in a non-lytic condition. Consequently, the experiment enabled
the visualization of peptide movements on the vesicle membranes at
different times, without membrane rupture. The positioning of each
peptide at different times of incubation is schematized in Fig. 9 (and
also in Figs. S1 to S3).
The interpretation of the sketch shown in Fig. 9 suggests that each
model proposed at different times of incubation just represents a snap-
shot of a long time course experiment (60 min), which initiated with
the Protonectarina-MP peptides incubated in water and in the presenceof the vesicles; under this condition the peptides presented a randomly
coiled chain (as demonstrated in Table 2). After a short time, the peptide
adsorbs to the lipidmembrane in an orientationmore-or-less parallel to
its surface. The positioning of the amide bonds protected from H/D ex-
change suggests that one or more peptide populations were adsorbed
to the vesicles. These populations, characterized by different contacts
with the bilayer are not “frozen” and along the incubation time the con-
formations of these populations change to optimize the amphipathicity,
leading to conformations more energetically favorable. A careful obser-
vation of themodels for the peptide–membrane interaction proposed in
Fig. 9 reveals the unusual insertion of charged side-chains of Asp and Lys
residues into the hydrophobic core of the membrane, which causes
membrane destabilization and contributes to the occurrence of frequent
conformational changes in the central region of peptide chain. Thus,
considering that both N- and C-termini remain positioned outside of
the membrane during most of the incubation time course, the frequent
conformational changes in the middle of peptide chain would contrib-
ute to the bilayer destabilization.
The positioning of the peptides in the bilayer under these condition
is not “frozen”, therefore the peptide molecules may eventually diffuse
on themembrane surface during all the experiment; under these condi-
tions, some regions of the membranes reach a critical concentration of
peptides, followed by the consequent leakage of vesicles. These results
support the hypothesis that the interaction of Protonectarina-MP-NH2
and Protonectarina-MP-OH with PC and PCPG membranes occurs
through the carpet model.
Orioni et al. [45] used a combination of ﬂuorescence spectroscopy
andmolecular dynamic simulations to determine that the antimicrobial
peptide PMAP-23C (which belongs to the group of cathelicidins) inter-
acts with the PCPG membrane vesicles by inserting itself below the
polar head groups of the phospholipids, with its chain orientated paral-
lel to the plane of the bilayer. They proposed that the mechanism of
bilayer destabilization involves an unusual insertion of charged side-
chains into the hydrophobic core of the membrane, like those reported
above in the present investigation. Milik and Skolnick [46] combined
techniques of Monte Carlo dynamic simulation with a hydropathy
scale method for the prediction of the association and the orientation
of the peptides in relation to themembrane surface. Thus, amodel of in-
teraction was proposed between Magainin-2 with biological mem-
branes in general, in which the peptide adsorbs on the membrane
surface forming a helical structure, which inserts some parts of the α-
carbon backbone into the core of the membrane, changing constantly
the conformation, but alwaysmaintaining its positioning almost parallel
in relation to the external surface of the membrane. This model of pep-
tide–membrane interaction seems to be very similar to that proposed
above for the Protonectarina-MP peptides.
The biological assays revealed that Protonectarina-MP-NH2 caused
potent mast cell degranulation followed by the delivery of a small
amount of LDH activity from the cytoplasm of mast cells, indicating
that the delivery of the content from the granules is mainly due to
mast cell degranulation, with a small contribution frommast cell mem-
braneperturbation. The amidatedpeptide also caused a small amount of
hemolysis in rat erythrocytes, in a similar manner to that reported
above for the mast cells. The acidic form of Protonectarina-MP present-
ed none of the biological activities reported for the amidated peptide.
Protonectarina-MP-NH2 was a very active antibiotic peptide for both
Gram-positive and Gram-negative bacteria, while Protonectarina-MP-
OH was poorly active under the same conditions. The amidation of the
C-terminal residue appears to be responsible for the stabilization of
the peptide conformation in a secondary structure that is richer in α-
helix content than its acidic congener. The helical, amphipathic confor-
mation, in turn, allows a deeper peptide–membrane interaction to
occur, favoring both biological activities that depend on ligand (pep-
tide) structure recognition by the GPCRs (such as exocytosis) and
those activities dependent onmembrane perturbation (such as hemoly-
sis and antibiosis).
Fig. 9. Scheme representing the interpretation models for the snapshots of the mass spectrometric analysis, showing the positioning of the α-carbon backbone of the peptides
Protonectarina-MP-NH2 and Protonectarina-MP-OH under interaction with PC and PCPG vesicles, in relation to the external medium and membrane core of the vesicles.
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The acidic or amidated condition of the C-terminal residue of the
mastoparans seems to inﬂuence the stabilization of these polycationic
peptides, and consequently their interactions with the target mem-
branes and/or the receptors located at thesemembranes. To investigate
the role of the C-terminus either as an amide or as a free acid, in
determining the molecular structures and biological activities of
these peptides, the mastoparan peptide Protonectarina-MP was
used as molecular model. The secondary structures of both forms of
this peptide were investigated using CD spectroscopy and molecular
modeling. Peptides presenting amidated or acidic C-terminus were
studied in relation to their interactions with anionic (PCPG) and
zwitterionic vesicles (PC), using measurements of dye leakage and
a combination of H/D exchange and mass spectrometry to monitor
peptide–membrane interactions. The C-terminal amidation pro-
motes the stabilization of the secondary structure of the peptide
with a relatively high content of helical conformations, when compared
to the peptide presenting acidic C-terminus, permitting a deeper inter-
action of the amidated mastoparan with the phospholipid constituents
of animal and bacterial cell membranes. Mast cell degranulation, hemo-
lysis and antibiosis assays were also performed using these peptides,
and the results were correlated with the structural properties of
the peptides, i.e., the amidated form of Protonectarina-MP was much
more active than the acidic ones. The results also suggested that
Protonectarina-MP interacts with the membranes in a way that both
terminal regions remain positioned outside the external surface of the
membrane, while the α-carbon backbone becomes partially embedded
in the membrane core and changing constantly the conformation, and
causing membrane destabilization.Conﬂict of interest statement
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Appendix A. Supplementary data
Figures S1 to S3 show the CID spectra of Protonectarina-MP-NH2
in the presence of PCPG vesicles and the CID spectra of Protonectarina-
MP-OH in the presence of PC and PCPG vesicles. This material is avail-
able free of charge via the Internet at www.elsevier.com.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2014.06.012.
References
[1] M.M. Javadpour, M.M. Juban, W.C. Lo, S.M. Bishop, J.B. Alberty, S.M. Cowell, C.L.
Becker, M.L. McLaughlin, De novo antimicrobial peptides with low mammalian
cell toxicity, J. Med. Chem. 39 (1996) 3107–3113.
[2] M. Dathe, T. Wideprecht, Structural features of helical antimicrobial peptides: their
potential to modulate activity on model membranes and biological cells, Biochim.
Biophys. Acta 1462 (1999) 71–87.
[3] M. Dathe, J. Meyer, M. Beyermann, B. Maul, C. Hoischen, M. Bienert, General aspects
of peptide selectivity towards lipid bilayers and cell membranes studied by variation
of the structural parameters of amphipathic helical model peptides, Biochim.
Biophys. Acta 1558 (2002) 171–186.
[4] T. Nakajima, Pharmacological biochemistry of vespid venoms, in: T. Piek (Ed.),
Venoms of the Hymenoptera: Biochemical, Pharmacological and Behavioural As-
pects, Academic Press Inc. Ltd., London, 1986, pp. 309–327.
[5] M.P. dos Santos Cabrera, B.M. de Souza, R. Fontana, K. Konno, M.S. Palma, W.F. de
Azevedo Jr., J. Ruggiero Neto, Conformation and lytic activity of Eumenine
Mastoparan: a new antimicrobial peptide from wasp venom, J. Pept. Res. 64
(2004) 95–103.
2368 A.V.R. da Silva et al. / Biochimica et Biophysica Acta 1838 (2014) 2357–2368[6] Y. Hori, M. Demura, M. Iwadate, A.S. Ulrich, T. Niidome, H. Aoyagi, T. Asakura,
Interaction of mastoparan with, membranes studied by 1H-NMR spectroscopy in
detergent micelles and by solid-state 2H-NMR and 15N-NMR spectroscopy in
oriented lipid bilayers, Eur. J. Biochem. 268 (2001) 302–309.
[7] R.L. Gallo, K.M. Huttner, Antimicrobial peptides: an emerging concept in cutaneous
biology, J. Investig. Dermatol. 111 (1998) 739–743.
[8] V. Krishnakumari, P. Nagaraj, Antimicrobial and hemolytic activities of Crabolin, a
13-residues peptide from the venom of the European hornet, Vespa crabro, and its
analogs, J. Pept. Res. 50 (1997) 88–93.
[9] M.A. Mendes, B.M. de Souza, M.R. Marques, M.S. Palma, Structural and biological
characterization of two novel peptides from the venom of the neotropical social
wasp Agelaia pallipes pallipes, Toxicon 44 (2004) 67–74.
[10] H.W. Huang, Action of antimicrobial peptides: two-state model, Biochemistry 39
(2000) 8347–8352.
[11] F.Y. Chen, H.W. Huang, Evidence for membrane thinning effect as the mechanism
for peptide-induced pore formation, Biophys. J. 84 (2003) 3751–3758.
[12] K. Matsuzaki,Why and how are peptides–lipid interactions utilized for self defence?
Magainins and tachyplesins as archetypes, Biochim. Biophys. Acta 1462 (1999)
1–10.
[13] Z. Oren, Y. Shai, Mode of action of linear amphipathic alpha-helical antimicrobial
peptides, Biopolymers 47 (1998) 451–463.
[14] K. Konno, M. Hisada, H. Naoki, Y. Itagaki, N. Kawai, A. Miwa, T. Yasuhara, Y.
Morimoto, Y. Nakata, Structure and biological activities of Eumenine Mastoparan-
AF (EMP-AF) a new mast cell degranulating peptide in the venom of the solytary
wasp (Anterhynchium ﬂavomarginatum micado), Toxicon 38 (2000) 1505–1515.
[15] M.L. Sforza, S. Oyama Jr., F. Canduri, C.C.B. Lorenzi, T. Pertinhez, K. Konno, B.M. de
Souza, M.S. Palma, J. Ruggiero Neto, W.F. Azevedo Jr., A. Spisni, How C-terminal
carboxyamidation alters the biological activity of peptides from the venom of the
Eumenine solitary wasp, Biochemistry 43 (2004) 5608–5617.
[16] J.Y. Kim, S.C. Park, M.Y. Yoon, K.S. Hahm, Y. Park, C-terminal amidation of PMAP-23:
translocation to the inner membrane of Gram-negative bacteria, Amino Acids 40
(2011) 183–195.
[17] S.R. Dennison, D.A. Phoenix, Inﬂuence of C-terminal amidation on efﬁcacy of
modelin 5, Biochemistry 50 (2011) 1514–1523.
[18] S.R. Dennison, F. Harris, T. Bhatt, J. Singh, D.A. Phoenix, The effect of C-terminal
amidation on the efﬁcacy and selectivity of antimicrobial and anticancer peptides,
Mol. Cell. Biochem. 332 (2009) 43–50.
[19] B.M. de Souza, M.S. Palma, Monitoring the positioning of short polycationic peptides
in model lipid bilayers by combining hydrogen/deuterium exchange and
electrospray mass spectrometry, Biochim. Biophys. Acta 1778 (2008) 2797–2805.
[20] J.A. Demmers, D.T. Rijkers, J. Haverkamp, J.A. Killian, A.J. Heck, Factors affecting gas-
phase deuterium scrambling in peptide ions and their implications for protein
structure determination, J. Am. Chem. Soc. 124 (2002) 11191–11198.
[21] K. Dohtsu, K. Okumura, K. Hagiwara, M.S. Palma, T. Nakajima, Isolation and sequence
analysis of peptides from de venom of Protonectarina sylveirae (Hymenoptera—
Vespidae), Nat. Toxins 1 (1993) 271–276.
[22] B.M. de Souza,M.A.Mendes, L.D. Santos, M.R. Marques, L.M.M. César, R.N.A. Almeida,
F.C. Pagnocca, K. Konno, M.S. Palma, Structural and functional characterization of
two novel peptide toxins isolated from the venom of the social wasp Polybia
paulista, Peptides 26 (2005) 2157–2164.
[23] B.M. de Souza, A.V.R. Silva, V.M.F. Resende, H.A. Arcuri, M.P. dos Santos Cabrera,
J. Ruggiero Neto, M.S. Palma, Characterization of two novel polyfunctional
mastoparan peptides from the venom of the social wasp Polybia paulista, Peptides
30 (2009) 1387–1395.
[24] J. Meletiadis, J.G.M. Meis, J.W. Mouton, J.P. Donnelly, P.E. Verweij, Comparison of
NCCLS and 3-(4,5dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide
(MTT) methods of in vitro susceptibility testing of ﬁlamentous fungi and develop-
ment of a new simpliﬁed method, J. Clin. Microbiol. 38 (2000) 2949–2954.
[25] G. Rouser, S. Fkeischer, A. Yamamoto, Two dimensional then layer chromatographic
separation of polar lipids and determination of phospholipids by phosphorus
analysis of spots, Lipids 5 (1970) 494–496.[26] C.A. Rohl, R.L. Baldwin, Deciphering rules of helix stability in peptides, Methods
Enzymol. 295 (1998) 1–26.
[27] Y. Todokoro, I. Yumen, K. Fukushima, S.W. Kang, J.S. Park, T. Kohno, K. Wakamatsu,
H. Akutsu, T. Fujiwara, Structure of tightly membrane-bound Mastoparan-X, a G-
protein-activating peptide, determined by solid-state NMR, Biophys. J. 91 (2006)
1368–1379.
[28] A.A. Schäffer, L. Aravind, T.L. Madden, S. Shavirin, J.L. Spouge, Y.I. Wolf, E.V. Koonin, S.
F. Altschul, Improving the accuracy of PSI-BLAST protein database searches with
composition-based statistics and other reﬁnements, Nucleic Acids Res. 29 (2001)
2994–3005.
[29] S.F. Altschul, T.L. Madden, A.A. Schäffer, J. Zhang, Z. Zang, W. Miller, D.J. Lipman,
Gapped. BLAST and PSI-BLAST: a new generation of protein database search pro-
grams, Nucleic Acids Res. 25 (1997) 3389–3402.
[30] A. Sali, T.L. Blundell, Comparative protein modelling by satisfaction of spatial re-
straints, J. Mol. Biol. 234 (1993) 779–815.
[31] R.A. Laskowsky, M.W. MacArthur, D.S. Moss, J.M. Thornton, PROCHECK: a program
to check the stereochemical quality of protein structures, J. Appl. Crystallogr. 26
(1993) 283–291.
[32] R. Koradi, M. Billeter, K. Wüthrich, MOLMOL: a program for display and analysis of
macromolecules structures, J. Mol. Graph. 14 (1996) 51–55.
[33] W. Humphrey, A. Dalke, K. Schulten, VMD: visual molecular dynamics, J. Mol. Graph.
14 (1996) 33–38.
[34] M.A. Mendes, B.M. de Souza, M.S. Palma, Structural and biological characterization
of three novel mastoparan peptides from the venom of the neotropical social
wasp Protopolybia exigua (Saussure), Toxicon 45 (2005) 101–106.
[35] F.W. McLafferty, Z.Q. Guan, U. Haupts, T.D. Wood, N.L. Kelleher, Gaseous conforma-
tional structures of Cytochrome C, J. Am. Chem. Soc. 120 (1998) 4732–4740.
[36] D.M. Saidemberg, N.B. Baptista-Saidemberg, M.S. Palma, Chemometric analysis
of Hymenoptera toxins and defensins: a model for predicting the biological ac-
tivity of novel peptides from venoms and hemolymph, Peptides 32 (2001)
1924–1933.
[37] L.D. Santos, J.R.A.S. Pinto, A.R.S. Menegasso, D.M. Saidemberg, A.M.C. Garcia, M.S.
Palma, Proteomic proﬁling of the molecular targets of interactions of the
mastoparan Polybia MP-III at the level of endosomal membranes from rat mast
cells, Proteomics 12 (2012) 2682–2693.
[38] H. Katayama, T. Ohira, K. Aida, H. Nagasawa, Signiﬁcance of a carboxyl-terminal
amidemoiety in the folding and biological activity of crustacean hyperglycemic hor-
mone, Peptides 23 (2002) 1537–1546.
[39] Y. Shai, Mechanism of the binding, insertion and destabilization of phospholipid bi-
layers membranes by R-helical antimicrobial and cell non-selective lytic peptides,
Biochim. Biophys. Acta 1462 (1999) 55–70.
[40] Y. Shai, Mode of action of membrane active antimicrobial peptides, Biopolymers 66
(2002) 236–248.
[41] N. Yokokawa, M. Komatsu, T. Takeda, T. Aizawa, T. Yamada, Mastoparan, a wasp
venom, stimulates insulin release by pancreatic islets through pertussis toxin sensi-
tive GTP-binding protein, Biochem. Biophys. Res. Commun. 158 (1989) 712–716.
[42] T. Higashijima, S. Uzu, T. Nakajima, E.M. Ross, Mastoparan, a peptide toxin from
wasp venom, mimics receptors by activating GTP-binding regulatory proteins
(G proteins), J. Biol. Chem. 263 (1988) 6491–6494.
[43] N.G. Park, Y. Yamato, S. Lee, G. Sugihara, Interaction of mastoparan-B from venom of
a hornet in Taiwan with phospholipid bilayers and its antimicrobial activity, Bio-
polymers 36 (1995) 793–801.
[44] T. Niidome, R. Kawakami, K. Okamoto, N. Ohmori, H. Mihara, H. Aoyagi, Interaction
of lipophilic peptides derived from mastoparan with phospholipid vesicles, J. Pept.
Res. 50 (1997) 458–464.
[45] B. Orioni, G. Bocchinfuso, J.Y. Kim, A. Palleschi, G. Grande, S. Bobone, Y. Park, J. Kim,
K.S. Hahm, L. Stella, Membrane perturbation by the antimicrobial peptide PMAP-23:
a ﬂuorescence and molecular dynamics study, Biochim. Biophys. Acta Biomembr.
1788 (2009) 1523–1533.
[46] M. Milik, J. Skolnick, Insertion of peptide chains into lipid membranes: an off-lattice
Monte Carlo dynamics model, Proteins Struct. Funct. Genet. 15 (1993) 10–25.
